Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-16,466
Closed -$3.25M 3347
2022
Q1
$3.25M Buy
16,466
+87
+0.5% +$2.71K ﹤0.01% 2284
2021
Q4
$3.24M Buy
16,379
+4,828
+42% +$322K ﹤0.01% 2333
2021
Q3
$2.28M Sell
11,551
-1,726
-13% -$183K ﹤0.01% 2610
2021
Q2
$2.23M Buy
13,277
+3,941
+42% +$690K ﹤0.01% 2656
2021
Q1
$1.64M Sell
9,336
-155
-2% -$31.3K ﹤0.01% 2705
2020
Q4
$1.94M Buy
9,491
+654
+7% +$121K ﹤0.01% 2524
2020
Q3
$1.73M Buy
+8,837
New +$2.13M ﹤0.01% 2455

Other funds holding GOCO

Nuveen's GOCO Position: Q2 2022 in Review

Nuveen sold out of GoHealth (GOCO) in Q2 2022, closing a stake of 16,466 shares — an estimated $3.25M sold.

Nuveen first reported a position in GOCO in Q3 2020 and held it in 7 quarters. The position peaked at $3.25M in Q1 2022. 77 funds tracked by Wall St. Rank hold GOCO as of Q2 2022.

  • Nuveen reported no remaining GoHealth position as of Q2 2022 after selling out during the quarter.
  • Nuveen sold 16,466 GoHealth shares in Q2 2022, an estimated $3.25M.
  • Nuveen first reported a position in GoHealth in Q3 2020 and held it in 7 quarters.
  • Nuveen's GoHealth position peaked at $3.25M in Q1 2022.
  • 77 funds tracked by Wall St. Rank held GoHealth as of Q2 2022.

Based on Nuveen's 13F filing for Q2 2022, filed 15 Aug 2022.